Impact Investors Inc Purchases 31 Shares of Mettler-Toledo International, Inc. $MTD

Impact Investors Inc boosted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 11.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 313 shares of the medical instruments supplier’s stock after acquiring an additional 31 shares during the period. Impact Investors Inc’s holdings in Mettler-Toledo International were worth $368,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. WPG Advisers LLC bought a new position in Mettler-Toledo International during the first quarter valued at about $41,000. Zions Bancorporation National Association UT bought a new stake in shares of Mettler-Toledo International in the 1st quarter valued at approximately $43,000. Golden State Wealth Management LLC grew its stake in shares of Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 35 shares during the period. Sound Income Strategies LLC grew its stake in shares of Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 43 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of Mettler-Toledo International by 520.0% in the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock valued at $73,000 after purchasing an additional 52 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,314.48 on Friday. The company has a market capitalization of $27.08 billion, a P/E ratio of 33.29, a PEG ratio of 3.90 and a beta of 1.37. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,486.76. The business’s 50 day simple moving average is $1,272.23 and its 200-day simple moving average is $1,186.35.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the business earned $9.65 EPS. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on MTD. Barclays upped their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research note on Thursday. Evercore ISI lowered their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Bank of America upped their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Saturday, September 27th. Finally, Robert W. Baird boosted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $1,328.33.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the company’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.